Prognostic significance of basic laboratory methods in non-small-cell-lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5473-5476

  Kaya, Vildan ^a   Yildirim, Mustafa ^b   Demirpence, Ozlem ^b   Yildiz, Mustafa ^c   Yalcin, Aysen Yesim ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ministry of Health Batman Regional Government Hospital   (Turkey)

^c Antalya Education and Research Hospital ^*  (Turkey)

Author keywords

Albumin; Inflammatory response; Lactate dehydrogenase; Non small cell lung cancer; Thrombocyte

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPHOCYTE; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEUTROPHIL; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; SURVIVAL RATE;

EID: 84887600340     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5473     Document Type: Article

References (29)

1. Ademuyiwa FO, Johnson CS, White AS, et al (2007). Prognostic factors in stage III non-small-cell lung cancer. Clin Lung Cancer, 8, 478-82.
2. Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, et al (2010). Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer, 10, 50.
3. Bagan P, Berna P, De Dominicis F, et al (2013). Nutritional status and postoperative outcome after pneumonectomy for lung cancer. Ann Thorac Surg, 95, 392-6.
4. Bashir Y, Graham TR, Torrance A, et al (1990). Nutritional state of patients with lung cancer undergoing thoracotomy. Thorax, 45, 183-6.
5. Caro JJ, Salas M, Ward A, Goss G (2001). Anaemia is an independent prognostic factor for survival in patients with cancer. Cancer, 91, 2214-21.
6. Carruthers R, Tho LM, Brown J, et al (2012). Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis, 14, 701-7.
7. Cedrés S, Torrejon D, Martínez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9.
8. Kawai H, Ota H (2012). Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg, 36, 2853-7.
9. Keizman D, Ish-Shalom M, Huang P, et al (2012). The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer, 48, 202-8.
10. Koukourakis MI, Giatromanolaki A, Sivridis E, et al (2003). Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer, 89, 877-85.
11. Kulesza P, Ramchandran K, Patel JD (2011). Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer. Am J Clin Pathol, 136, 228-38.
12. Littlewood TJ, Bajetta E, Nortier JW, et al (2001). Epoetin Alfa Study Group. Effects of epoetin alfa on haematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol, 19, 2865-74.
13. Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306.
14. McMillan DC (2009). Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 12, 223-6.
15. Nakahara Y, Mochiduki Y, Miyamoto Y, et al (2005). Prognostic signifificance of the lymphocyte-to-neutrophil ratio in percutaneous fifine-needle aspiration biopsy specimens of advanced non-small cell lung carcinoma. Cancer, 104, 1271-80.
16. Pircher A, Ulsperger E, Hack R, et al (2011). Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. Anticancer Res, 31, 2949-55.
17. Rozhin J, Sameni M, Ziegler G, Sloane BF (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res, 54, 6517-25.
18. Sharma R, Zucknick M, London R, et al (2008). Systemic inflflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer, 7, 331-7.
19. Sánchez-Lara K, Turcott JG, Juárez E, et al (2012). Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer, 64, 526-34.
20. Sarraf KM, Belcher E, Raevsky E, et al (2009). Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg, 137, 425-8.
21. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
22. Smith RA, Ghaneh P, Sutton R, et al (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1068-73.
23. Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8.
24. Tomita M, Shimizu T, Ayabe T, et al (2011). Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res, 31, 2995-8.
25. Vaupel P, Thews O, Hoeckel M (2001). Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol, 18, 243-59.
26. Vlachostergios PJ, Gioulbasanis I, Kamposioras K, et al (2011). Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients. Oncology, 81, 113-8.
27. Wang JY, Chen KY, Wang JT, et al (2002). Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys, 54, 735-41.
28. Yao Y, Yuan D, Liu H, et al (2013). Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother, 62, 471-9.
29. Zhang J, Huang SH, Li H, et al (2013). Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol, 30, 352-3.